Vote Scores

Home / Companies / ORCHARD THERAPEUTICS PLC / 19 Dec 2023

Meeting · year to 30 June 202456 filers reporting

ORCHARD THERAPEUTICS PLC: meeting of 19 Dec 2023

Votes reported on Form N-PX, item by item

56 Form N-PX filers reported votes at the ORCHARD THERAPEUTICS PLC meeting of 19 Dec 2023. Their records fall into 5 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.

foragainstabstain, withhold or otheramber tick: the portion cast against management

Items

1

SECTION 14A SAY-ON-PAY VOTESIssuer

Advisory vote on executive pay (say-on-pay)

59 vote records from 51 filers. 19 of the 41 filers that marked the item either way voted against management. 10 filers reported this item without a management mark.

41.2% for39.2% against19.6% other46.3% against management51 filers49.5% for50.5% against0.0% other50.5% against management4,452,623 reported shares
2

EXTRAORDINARY TRANSACTIONSIssuer

EXTRAORDINARY TRANSACTIONS: management items

Management items in this category are shown together; filers word and number them differently.

12 vote records from 4 filers. 0 of the 4 filers that marked the item either way voted against management.

100.0% for0.0% against0.0% against management4 filers100.0% for0.0% against0.0% against management1,770,676 reported shares, counted once per item in this group
3

CAPITAL STRUCTUREIssuer

CAPITAL STRUCTURE: management items

Management items in this category are shown together; filers word and number them differently.

8 vote records from 4 filers. 0 of the 4 filers that marked the item either way voted against management.

100.0% for0.0% against0.0% against management4 filers100.0% for0.0% against0.0% against management54,000 reported shares, counted once per item in this group
4

COMPENSATIONIssuer

COMPENSATION: management items

Management items in this category are shown together; filers word and number them differently.

4 vote records from 4 filers. 0 of the 4 filers that marked the item either way voted against management.

100.0% for0.0% against0.0% against management4 filers100.0% for0.0% against0.0% against management27,000 reported shares, counted once per item in this group
5

CORPORATE GOVERNANCEIssuer

CORPORATE GOVERNANCE: management items

Management items in this category are shown together; filers word and number them differently.

6 vote records from 3 filers. 0 of the 3 filers that marked the item either way voted against management.

100.0% for0.0% against0.0% against management3 filers100.0% for0.0% against0.0% against management302,056 reported shares, counted once per item in this group

How the largest families voted

Family1. Say-on-pay
VanguardAgainst *
FidelityAgainst *
Goldman SachsSplit or no vote
Columbia ThreadneedleAgainst *
Federated HermesAgainst *
Neuberger BermanFor

* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.

Questions

How did large funds vote at the ORCHARD THERAPEUTICS PLC meeting?

56 Form N-PX filers reported votes at the meeting of 19 Dec 2023. On say-on-pay, 19 of 41 voted against management (46.3%). The family table lists each of the largest families item by item.

Is this the meeting result?

No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by ORCHARD THERAPEUTICS PLC on Form 8-K.

Why are director elections shown as counts only?

Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.

Every meeting on file for ORCHARD THERAPEUTICS PLC

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing ORCHARD THERAPEUTICS PLC with a meeting date within three days of 19 Dec 2023. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 30 Sep 2026.